Open access · OA
via OpenAlex
PS61. Immune-inflammatory markers: as a potential biomarker for staging bipolar disorder
Nam Hee Yoo, Jung Won Kim, Hwang-Bin Lee
The International Journal of Neuropsychopharmacology · 2016 · ▲ 1 citations
Abstract
Abstract Objective: In this study, we evaluated the changes of peripheral immune-inflammatory markers relevant to the clinical course in patients with bipolar disorder to look into the possibility of immune-inflammatory markers as a potential biomarker for staging bipolar disorder(BD). Method: Patients with BD and healthy controls were compared to see the abnormalities in peripheral immune-inflammatory markers using TNF-alpha, IL-6, mcp1/ccl2, CRP, BDNF, and Vitamin D. We also evaluated the changes of peripheral immune-inflammatory markers episodically in response to the clinical course and mood states e.g. acute, continuation and maintenance phase. Results: A total of 17 patients with bipolar mania(60%female; mean age 46.8±10.6 years; mean duration of illness 16.2±10.6 years; mean YMRS scores 43.4±4.5; mean MADRS scores 1.8±3.0) and 40 healthy controls (52.6%female; mean age 38.7±14.1years) were enrolled. There were no statistically significant differences between the two groups for sex and age. IL-6 and CRP were consistently increased in BD compared with control group. The result for IL-6 showed that the mean difference is 2.64±0.80 pg/mL(p=0.002) in acute phase and 1.38±0.56 pg/mL(p=0.018) in maintenance phase. The result for CRP showed that the mean difference is 4.95±1.42 mg/L(p=0.001) in acute phase and 1.33±0.59 mg/L(p=0.028) in maintenance phase. MCP1/CCL2 was changed episodically in response to the clinical course and mood states (359.7±82.3 pg/mL in acute phase, 243.6±66.9 pg/mL in continuation phase, 299.4±81.5 pg/mL in maintenance phase, p=0.002). Conclusion: Our results suggest that immune-inflammatory activity is possible to be correlated with the episodic clinical course of BD. Larger samples of BD should be studied for further investigation.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1093/ijnp/pyw043.061
- Canonical
- link ↗
- Fetched
- 2026-10-15 MST
Cite this
APA
Yoo, N.H., Kim, J.W., & Lee, H. (2016). PS61. Immune-inflammatory markers: as a potential biomarker for staging bipolar disorder. <em>The International Journal of Neuropsychopharmacology</em>. https://doi.org/10.1093/ijnp/pyw043.061
Vancouver
Yoo NH, Kim JW, Lee H. PS61. Immune-inflammatory markers: as a potential biomarker for staging bipolar disorder. The International Journal of Neuropsychopharmacology. 2016. doi:10.1093/ijnp/pyw043.061.
BibTeX
@article{nam2016PSImmu,
title = {PS61. Immune-inflammatory markers: as a potential biomarker for staging bipolar disorder},
author = {Nam Hee Yoo and Jung Won Kim and Hwang-Bin Lee},
journal = {The International Journal of Neuropsychopharmacology},
year = {2016},
doi = {10.1093/ijnp/pyw043.061},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Journal of Clinical Medicine 2025
Open access · CC-BY
Serum Galectin-3 and IL-6 as Inflammatory Markers in Bipolar Disorder: Insights from Manic and Euthymic Episodes
Preprints.org 2023
Preprint · CC-BY
Association of Genetic Polymorphisms with Longevity in the population of the Sardinian Blue Zone
Egyptian Journal of Medical Human Genetics 2024
Open access · CC-BY
DNA methylation of ELOVL2 gene as an epigenetic marker of age among Egyptian population
PubMed 2013
Preprint
Genomic damage in patients with type-2 diabetes mellitus.
Aging 2021
Preprint · CC-BY
Potential reversal of epigenetic age using a diet and lifestyle intervention: a pilot randomized clinical trial
Anaesthesia Pain & Intensive Care 2025
Open access · CC-BY